Clinical significance of serum miR-101-3p expression in patients with neonatal sepsis.

IF 1.7 4区 医学 Q3 PHARMACOLOGY & PHARMACY Personalized medicine Pub Date : 2021-09-01 Epub Date: 2021-10-06 DOI:10.2217/pme-2020-0182
Juan Zhang, Xinwei Xu, Min Wang
{"title":"Clinical significance of serum <i>miR-101-3p</i> expression in patients with neonatal sepsis.","authors":"Juan Zhang,&nbsp;Xinwei Xu,&nbsp;Min Wang","doi":"10.2217/pme-2020-0182","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> This study aimed to evaluate the levels and functions of <i>miR-101-3p</i> in neonatal sepsis (NS). <b>Materials & methods:</b> Quantitative real-time PCR was conducted to investigate the expression of <i>miR-101-3p</i> and the receiver operating characteristic curve was applied to manifest its diagnostic effects. <b>Results:</b><i>miR-101-3p</i> was increased in the NS patients and the dysregulation of <i>miR-101-3p</i> was associated with levels of procalcitonin, CRP, IL-8 and TNF-α. The combination of <i>miR-101-3p</i> and procalcitonin could function as a promising indicator in distinguishing NS patients. The silenced <i>miR-101-3p</i> reversed the increased levels of TNF-α and IL-8 caused by lipopolysaccharide <i>in vitro</i>. <i>DUSP1</i> was identified as a direct target gene of <i>miR-101-3p</i> in NS. <b>Conclusion:</b> The abundance of <i>miR-101-3p</i> facilitated the inflammation in NS by targeting <i>DUSP1</i>.</p>","PeriodicalId":19753,"journal":{"name":"Personalized medicine","volume":"18 6","pages":"541-550"},"PeriodicalIF":1.7000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Personalized medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2217/pme-2020-0182","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/10/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 7

Abstract

Aim: This study aimed to evaluate the levels and functions of miR-101-3p in neonatal sepsis (NS). Materials & methods: Quantitative real-time PCR was conducted to investigate the expression of miR-101-3p and the receiver operating characteristic curve was applied to manifest its diagnostic effects. Results:miR-101-3p was increased in the NS patients and the dysregulation of miR-101-3p was associated with levels of procalcitonin, CRP, IL-8 and TNF-α. The combination of miR-101-3p and procalcitonin could function as a promising indicator in distinguishing NS patients. The silenced miR-101-3p reversed the increased levels of TNF-α and IL-8 caused by lipopolysaccharide in vitro. DUSP1 was identified as a direct target gene of miR-101-3p in NS. Conclusion: The abundance of miR-101-3p facilitated the inflammation in NS by targeting DUSP1.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新生儿脓毒症患者血清miR-101-3p表达的临床意义
目的:本研究旨在探讨miR-101-3p在新生儿脓毒症(NS)中的表达水平及功能。材料与方法:采用实时荧光定量PCR检测miR-101-3p的表达情况,并采用受试者工作特征曲线来体现其诊断效果。结果:miR-101-3p在NS患者中升高,miR-101-3p失调与降钙素原、CRP、IL-8、TNF-α水平相关。miR-101-3p与降钙素原的联合表达可作为鉴别NS患者的一个有希望的指标。沉默的miR-101-3p在体外逆转脂多糖引起的TNF-α和IL-8水平升高。DUSP1被鉴定为NS中miR-101-3p的直接靶基因。结论:miR-101-3p丰度通过靶向DUSP1促进NS炎症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Personalized medicine
Personalized medicine 医学-药学
CiteScore
3.30
自引率
4.30%
发文量
49
审稿时长
6-12 weeks
期刊介绍: Personalized Medicine (ISSN 1741-0541) translates recent genomic, genetic and proteomic advances into the clinical context. The journal provides an integrated forum for all players involved - academic and clinical researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organizations and others in the healthcare community. Personalized Medicine assists these parties to shape thefuture of medicine by providing a platform for expert commentary and analysis. The journal addresses scientific, commercial and policy issues in the field of precision medicine and includes news and views, current awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles.
期刊最新文献
Challenges and opportunities in building a health economic framework for personalized medicine in oncology. Developing and validating noninvasive prenatal testing for de novo autosomal dominant monogenic diseases in Vietnam. Budget impact and transferability of cost-effectiveness of DPYD testing in metastatic breast cancer in three health systems. Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation. Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1